Emma Kinloch
Emma is the CEO of Salivary Gland Cancer UK (SGC UK) and focussed on furthering research and improving outcomes for rare Salivary Gland Cancers.
Emma is a member of the Experimental Cancer Medicines Centre (ECMC) strategy advisory board, an advisor to the European Reference Network (ERN) EURACAN rare Head and Neck cancer domain and, a non-executive director of the Adenoid Cystic Carcinoma Research Foundation (ACCRF).
After graduating in Experimental Psychology from Corpus Christi College, Oxford, Emma pursued a successful career in finance, working in both Europe and Asia. Recently she completed a Professional Doctorate in Occupational Health Psychology, focussed on Head and Neck Cancer and Work.
Emma has a strong commitment to supporting and building mission-driven organisations with strong governance, who put the needs of people first and seek to make the world a fairer place. In all her roles she brings a distinctive blend of corporate leadership, academic insight, and lived experience.